Psychemedics Corporation

Psychemedics pioneered the use of hair drug testing, and remains by far the largest and leading supplier of drugs of abuse hair testing worldwide. Psychemedics is the only company to develop and patent a process that releases virtually 100% of the drugs from the inside of the hair, providing the greatest ability to detect drug use. Offering over 25 years of global experience, Psychemedics has provided its expertise and superior drug testing technology to thousands of organizations to aid in transitioning their drug screening programs to achieve the goal of a drug-free environment. Our drug testing services are trusted by over 10% of the Fortune 500 companies, numerous international organizations, many of the largest police departments, rehabilitation programs, schools and parents throughout the world. Psychemedics established its scientific and market leadership position through dedicated research and development efforts. Psychemedics has set the industry standards for sensitivity, robustness, quality and consistency. A partnership with Psychemedics ensures that your drug testing program stays current as drug challenges change and evolve.
Type
Public
HQ
Acton, US
Founded
1985
Size (employees)
206 (est)+34%
Psychemedics Corporation was founded in 1985 and is headquartered in Acton, US

Psychemedics Corporation Office Locations

Psychemedics Corporation has an office in Acton
Acton, US (HQ)
200 125 Nagog Park

Psychemedics Corporation Metrics

Psychemedics Corporation Financial Metrics

Revenue (2016)

$39 m

Revenue growth (2015-16), %

45%

Net income (2016)

$6.7 m

Market capitalization (28-Apr-2017)

$104.1 m

Closing share price (28-Apr-2017)

$19

Cash (31-Dec-2016)

$3.9 m
Psychemedics Corporation's current market capitalization is $104.1 m.
Psychemedics Corporation's revenue was reported to be $39 m in FY, 2016 which is a 45% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$26.9 m$29.2 m$27 m$39 m

Revenue growth, %

9%(8%)45%

Net Income

$3.8 m$3.2 m$1.5 m$6.7 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$4 m$3.6 m$2.7 m$3.9 m

Accounts Receivable

Inventories

$769.3 k$690 k$1.1 m$1.1 m

Current Assets

$10 m$10.6 m$8.5 m$10.9 m

Total Assets

$16.5 m$24.1 m$22.4 m$25 m

Accounts Payable

$510.6 k$845.1 k$747.3 k$1.4 m

Total Debt

$6.2 m$5.9 m$3.4 m

Current Liabilities

$3 m$3.6 m$3.6 m$4.5 m

Additional Paid-in Capital

$28.9 m$29.5 m$30 m$30.6 m

Retained Earnings

($6.6 m)($6.6 m)($8.3 m)($4.9 m)

Total Equity

$12.3 m$12.8 m$11.7 m$15.6 m

Debt to Equity Ratio

0.5 x0.5 x0.2 x

Debt to Assets Ratio

0.3 x0.3 x0.1 x

Financial Leverage

1.3 x1.9 x1.9 x1.6 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$3.8 m$3.2 m$1.5 m$6.7 m

Depreciation and Amortization

$872.2 k$1.1 m$1.7 m$2.3 m

Accounts Receivable

$251.9 k$290.7 k$539.4 k($2.3 m)

Inventories

Accounts Payable

($159.2 k)$334.5 k($97.8 k)$144 k

Cash From Operating Activities

$6 m$4.5 m$4.6 m$9.3 m

Cash From Investing Activities

($1.8 m)($7.8 m)($1.8 m)($2.1 m)

Dividends Paid

($3.2 m)($3.2 m)($3.2 m)($3.3 m)

Cash From Financing Activities

($3.3 m)$3 m($3.7 m)($5.9 m)

Interest Paid

$77 k$128.3 k$134 k

Income Taxes Paid

$1.2 m$1.2 m$39.8 k$1.8 m

Psychemedics Corporation Market Value History

Psychemedics Corporation Online Presence

Psychemedics Corporation Company Life

You may also be interested in